Stock Price
3.24
Daily Change
0.04 1.25%
Monthly
4.52%
Yearly
32.24%
Q3 Forecast
3.18

Acasti Pharma reported $3.09M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Acasti Pharma USD 3.09M 49.05M Jun/2025
Addus HomeCare USD 316.56M 9.36M Jun/2025
Amarin USD 58.77M 56.06M Mar/2025
Cassava Sciences USD 14.09M 15.4M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Option Care Health USD 1.33B 79.59M Jun/2025
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024